science5 distinct publishers
Two doses of psilocybin protected mouse nerves through six rounds of cisplatin
The protection ran through the same serotonin receptor that carries the hallucinations, though a non-hallucinogenic compound worked too, and a randomised trial in about 80 patients is due to start in November.
Perspective Coverage
5 publishers- Builder
- Builder 39%
- Operator
- Operator 38%
- Investor
- Investor 23%
Reality
- Evidence70
- Adoption8
- Hype gap+20